Research Paper Volume 15, Issue 16 pp 8113—8136
Comprehensive characterization of pyroptosis phenotypes with distinct tumor immune profiles in gastric cancer to aid immunotherapy
Figure 5. Pyroptosis genomic phenotypes with distinct prognosis and immune landscapes in the gastric cancer meta-cohort. (A) Kaplan-Meier survival curves for three pyroptosis genomic phenotypes (log-rank test). (B) The relative abundance of 28 immune cells among three pyroptosis genomic phenotypes through ssGSEA. (C–E) The immune score, stromal score, and tumor purity across three genomic phenotypes. (F) The mRNA expression of immune checkpoints across three genomic phenotypes. The asterisks indicated the statistical p-values (*p < 0.05; ***p < 0.001) and ns indicated not significant.